Keyphrases
High Dose
100%
Economic Impact
100%
Oral Corticosteroids
100%
Juvenile Dermatomyositis
100%
Corticosteroid Treatment
100%
Intravenous Corticosteroids
100%
Incremental Cost-effectiveness Ratio
40%
Medical Center
20%
Resource Use
20%
Cost-effectiveness Analysis
20%
Treatment Protocol
20%
Medical Records
20%
Disease Severity
20%
Remission
20%
Resource Cost
20%
Myositis
20%
Myositis Autoantibody
20%
Time to Remission
20%
Cost Identification
20%
Medicine and Dentistry
Drug Megadose
100%
Juvenile Dermatomyositis
100%
Corticosteroid Therapy
100%
Health Care Cost
100%
Cost-Effectiveness Analysis
75%
Myositis
50%
Diseases
25%
Disease Severity
25%
Autoantibodies
25%
Immunology and Microbiology
Drug Megadose
100%
Dermatomyositis
100%
Myositis
66%
Autoantibodies
33%
Medical Record
33%
Pharmacology, Toxicology and Pharmaceutical Science
Juvenile Dermatomyositis
100%
Remission
66%
Myositis
66%
Disease Severity
33%
Disease
33%
Autoantibodies
33%
Biochemistry, Genetics and Molecular Biology
Drug Megadose
100%
Medical Record
50%
Autoantibodies
50%